Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 321 results for "pfizer"

French drugmaker Cellectis in sale talks -FT

French cancer drugmaker Cellectis is in potential sale talks with a few suitors, including U.S. based Pfizer Inc, the Financial Times reported citing people familiar with the matter. Although no Yahoo! UK and Ireland, 3 hours ago
French bio tech company Cellectis in sale talks FirstWord Pharma, 4 hours ago
[x]  

273 images for pfizer

Ticker Report, 1 day ago
American Banking News - Forex, 1 day ago
St. Thomas Times-Journal, 3 hours ago
WealthManagement.com, 2 days ago
Business Insider, 4 days ago
Bloomberg, 6 days ago
Palestine Telegraph, 6 days ago
One News Page United Kingdom, 6 days ago
Guru Focus, 9 hours ago
Sydney Morning Herald, 6 days ago

FDA clears Pfizer's Rapamune for rare lung disease

News Editor The FDA approves Pfizer's (NYSE:PFE) Rapamune (sirolimus) for the treatment of lymphangioleiomyomatosis (LAM), a rare, progressive lung disease almost exclusively affecting women caused by mutations in the TSC1 gene. The disorder is ...
 Seeking Alpha3 hours ago FDA approves Pfizer's Rapamune for lymphangioleiomyomatosis  FirstWord Pharma3 hours ago

FDA app proves Pfizer drug to treat very rare lung disease

WASHINGTON The drug, Rapamune, known chemically as sirolimus, is made by Pfizer Inc and is designed to treat lymphangioleiomyomatosis (LAM), a disease that causes lung damage and affects only two to five women per million worldwide. The drug was ...
 Reuters4 hours ago FDA approves Pfizer drug to treat very rare lung disease  NewsR.in8 minutes ago UPDATE 1-FDA approves Pfizer drug to treat very rare lung disease  Reuters2 hours ago FDA approves Pfizer drug to treat rare lung disease  Channel NewsAsia2 hours ago
[x]  

Pfizer (PFE) Trading Near $33.88 Support Level

After WednesdayaEUR(TM)s trading in Pfizer Inc. (http://www.marketintelligencecenter.com/symbol/PFE"PFE) MarketIntelligenceCenter.com's patented algorithms uncovered a trade that offers a 2.60% return or 11.14% on an annualized basis (for comparison ...
 Individual.com12 hours ago Potential Pfizer (PFE) Trade Has 3.02% Downside Protection  Individual.com1 day ago Pfizer (PFE) Breaks Through Support at $34.18  Individual.com2 days ago Next Support Level for Pfizer (PFE) is $34.07  Individual.com2 days ago

Why Pfizer's Pursuit Of AstraZeneca Continues To Shape The Outlook Of Both Companies

 Forbes.com12 hours ago
Seeking Alpha

Is Shire A Takeover Target For Pfizer?

Pfizer has identified strategic areas that it wants to target in the next 4 years, including biosimilars and rare diseases. The biosimilar focus helped spur an acquisition of Hospira earlier in 2015, and Shire appears to be positioned as the next ...
 Seeking Alpha1 day ago Is A Big Acquisition Is Due For Pfizer?  Trefis8 hours ago Pfizer Acquires Minority Interest in AM-Pharma; Secures Option to Acquire Company  Pharmacy Choice1 day ago Analyst Says GlaxoSmithKline Acquisition Will Benefit Pfizer  Guru Focus6 days ago
[x]  
InsiderMonkey.com

Actavis PLC (ACT), Pfizer Inc. (PFE) Among the Most Popular Healthcare Stocks of Billionaire Investors

Insider Monkey strives to always keep investors updated on diverse stocks across different industries. Now that the 13F filings are in for the reporting period of March 31, weve been able to analyze the data and produce dozens of reports on the ...
 InsiderMonkey.com1 day ago Pfizer's Buy Rating Reiterated at Jefferies Group (PFE)  WKRB News9 hours ago Pfizer Given Buy Rating at Jefferies Group (PFE)  Ticker Report2 days ago Pfizer Receives Buy Rating from Deutsche Bank (PFE)  Mideast Time3 days ago
[x]  

Pfizer in talks to acquire Cellectis: report

According to people familiar with the matter, Pfizer has entered into negotiations to acquire French biotech firm Cellectis, in a deal that could be valued to about 1.5 billion euros ($1.6 billion), the Financial Times reported Thursday. Two people ...
 FirstWord Pharma2 hours ago Buzz: Cellectis could be in line for a $1.6B Pfizer buyout  FierceBiotech2 hours ago Cellectis jumps 14% on talks of sale to Pfizer  Fnews.com4 hours ago Cellectis shares jump on report  Wall Street Business Network4 hours ago
[x]  

Pfizer offers $3 million in breast cancer grants

Pfizer Inc. today announced the launch of a competitive, peer-reviewed grants program to support clinical research projects investigating IBRANCE (palbociclib) in advanced breast cancer. The multi-year program, which will award a total of up to $3 ...
 PharmaceuticalProcessing8 hours ago Pfizer Announces $3 Million Grants Program to Further Clinical Research in Advanced Breast Cancer  PredictWallStreet12 hours ago Pfizer Announces $3M Grants Program to Further Clinical Research in Advanced Breast Cancer  Benzinga.com12 hours ago PFIZER : Announces $3 Million Grants Program to Further Clinical Research in Advanced Breast Cancer  4 Traders11 hours ago
[x]  

PFIZER : announces 51 grants

May 28 -- Pfizer Inc. has announced that 51 nonprofits in Connecticut and Rhode Island , including the Garde Arts Center and Project Oceanology, will receive funding support this year. Other recipients were Aluminum Falcon Robotics, Bethsaida ...
 4 Traders5 hours ago Pfizer announces 51 grants [The Day, New London, Conn.]  Bloomberg5 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - pfizer
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less